In this study, we demonstrated that the CXCR4/CXCL12 pathway was upregulated in the primary tumor and in the matched macrometastatic SLNs of luminal B BC patients who had tumor recurrence, and it was associated with characteristics of tumor aggressiveness and invasiveness such as LN involvement. Here, CXCL12 is linked to breast cancer.